Lipitor, Plavix lead list of 10 most-sold drugs since 2000

11/8/2012 | Genetic Engineering & Biotechnology News

Pfizer's Lipitor, or atorvastatin, topped Genetic Engineering & Biotechnology News' list of best-selling drugs between 2000 and 2011 based on publicly available sales figures. Lipitor generated sales of $121.4 billion during the period. Bristol-Myers Squibb and Sanofi's Plavix, or clopidogrel, came in second with $74.6 billion, followed by GlaxoSmithKline's Advair with $58.8 billion. Rounding out the top 10 were Eli Lilly and Co.'s Zyprexa, Amgen's Enbrel, AstraZeneca's Nexium, Merck & Co.'s Singulair, AstraZeneca's Seroquel, Sanofi's Lovenox and Abbott Laboratories' Humira.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA